Informing decisions concerning adjuvant chemotherapy following surgical resection for non-small cell lung cancer: a mathematical modelling study.
Faced with the problem of giving individualised advice about adjuvant chemotherapy to patients who have had an apparently curative lung cancer resection, we propose a model to help clarify the choices being made. This would inform the clinician, help the patient and be an explicit basis on which to initiate the discussion.
Utley
Martin
M
Clinical Operational Research Unit, UCL, London, United Kingdom.
Paschalides
Christos
C
Treasure
Tom
T
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D017024:Chemotherapy, Adjuvant; D003657:Decision Making; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D008962:Models, Theoretical; D009367:Neoplasm Staging; D011013:Pneumonectomy; D012107:Research Design; D016019:Survival Analysis; D016896:Treatment Outcome
D000970:Antineoplastic Agents